Erik Skof

A Three-Dose mRNA COVID-19 Vaccine Regime Produces Both Suitable Immunogenicity and Satisfactory Efficacy in Patients with Solid Cancers

P. Korošec, M. Rijavec, E. Škof, 2023, Vaccines.